Clinical trial
A Phase I Dose-Ranging Study of Oral L-citrulline in Steady-State Sickle Cell
NCT02659644 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Dose-Ranging Study of Oral L-citrulline in Steady-State Sickle Cell
- Lead sponsor
- University of Mississippi Medical Center
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- December 31, 2015
- Completion date
- December 31, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease